Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Discovery Platform
Sponsor : Google Ventures
Deal Size : $67.0 million
Deal Type : Series A Financing
Delphia Therapeutics Launches to Innovate Cancer Medicines through Activation Lethality
Details : Proceeds will support advanced cancer medicines aimed at significant anti-tumor activity across multiple prevalent cancer types.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
February 05, 2024
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Discovery Platform
Sponsor : Google Ventures
Deal Size : $67.0 million
Deal Type : Series A Financing